Previous 10 | Next 10 |
THE WOODLANDS, Texas, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that data from five posters highlighting XERMELO ® (telotristat ethyl) will be presented at the upcoming North American Neuroendocrine Tumor Society Annual Multi...
Gainers: Dova Pharmaceuticals (NASDAQ: DOVA ) +38% . USA Technologies ( OTC:USAT ) +28% . Farmmi (NASDAQ: FAMI ) +24% . Thor Industries (NYSE: THO ) +21% . GTT Communications (NYSE: GTT ) +15% . Patrick Industries (NASDAQ: PATK ) +12% . Seattle Genetics (NASDAQ: SGEN ) +10% . ...
Lexicon Pharmaceuticals (NASDAQ: LXRX ) is now off 13.8% today on heavy volume following a very bearish take from Seeking Alpha contributor Mako Research. More news on: Lexicon Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
The Sanofi termination is a disaster for LXRX shareholders and the cash burn will increase dramatically On July 25 th , Lexicon Pharmaceuticals ( LXRX ) received notice from Sanofi ( SNY ) ‘purporting’ to terminate their key alliance around the SGLT2 inhibitor sotagliflozin...
"Men in rage strike those that wish them best. ”― William Shakespeare, Othello The market broke its three-week winning streak last week. The Dow was off approximately one percent while the Russell 2000 declined just slightly more on a percentage basis. Both the S&P 500 a...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
Lexicon Pharmaceuticals (NASDAQ: LXRX ) is up 1.5% postmarket after an insider purchase from its CEO. More news on: Lexicon Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
Gainers: SPI Energy Co. (NASDAQ: SPI ) +42% . Lexicon Pharmaceuticals (NASDAQ: LXRX ) +22% . DAVIDsTEA (NASDAQ: DTEA ) +17% . Dynagas LNG Partners LP (NYSE: DLNG ) +12% . Edesa Biotech (NASDAQ: EDSA ) +12% . SCYNEXIS (NASDAQ: SCYX ) +11% . Eyenovia (NASDAQ: EYEN ) +10% . elect...
News, Short Squeeze, Breakout and More Instantly...
Lexicon Pharmaceuticals Inc. Company Name:
LXRX Stock Symbol:
NASDAQ Market:
Lexicon Pharmaceuticals Inc. Website:
THE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that senior company execut...
THE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024. The event will be held in New York City from 9:00 a...
THE WOODLANDS, Texas, April 03, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced Jeff Wade, Lexicon’s president and chief financial officer, Tom Garner, Lexicon’s senior vice president and chief commercial officer, and Craig Granowitz, M.D., ...